Al Barqawi MD FRCS (Glasg)

​Kill Only the Cancer & Preserve Quality of Life


Associate Clinical Professor Surgery/Urology

Director of the prostate cancer fellowship program

University of Colorado Denver School of Medicine

12631 East 17th Ave., Room L15-5602,

Academic Office One Bldg. MS C-319

Aurora, CO 80045

720-848-1800 - CLINIC

303-724-2722 - OFFICE

fax: 303-724-2818

-------------------------------------------


Dr. Barqawi performed the first focal stereotactic interstitial laser treatment of prostate cancer guided by MRI thermal imaging

Dr. Barqawi also conducted the first trial in the US using (Botox) injections for the treatment of BPH (Enlarged Prostate) related lower urinary symptoms​

Dr. Barqawi performed more than a thousand cryotherapy procedures to treat prostate cancer with excellent results

The Facts

Prostate Cancer affects more than a quarter million men in the USA every year.

One out of ten of these men will die from prostate cancer.

Widespread screening has been cited to cause over diagnosis of the disease.

The majority of these men will survive the disease regardless of treatment.

The Challenges

The treatment options available for early stage organ-confined and low risk prostate cancer have been controversial.

A substantial number of men diagnosed with prostate cancer are over treated.

The current treatment options; including radical prostatectomy and radiation therapy are associated with significant long term side effects.